![Cyrus Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrus Harmon
Fondateur chez
OLEMA PHARMACEUTICALS, INC.
Fortune : 7 M $ au 30/09/2026
Profil
Dr. Cyrus L.
Harmon is a President & Chief Executive Officer at Vilya, Inc. and an Independent Director at Olema Pharmaceuticals, Inc. He is on the Board of Directors at Olema Pharmaceuticals, Inc. Dr. Harmon was previously employed as a General Manager by Affymetrix, Inc. and a Chief Executive Officer by Neomorphics, Inc. He received his undergraduate degree from the University of California, Berkeley and a doctorate degree from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/07/2026 | 819 798 ( 0,94 % ) | 7 M $ | 30/09/2026 |
Postes actifs de Cyrus Harmon
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Fondateur | 07/08/2006 |
Vilya Inc.
 Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Directeur Général | 01/10/2023 |
Anciens postes connus de Cyrus Harmon
| Sociétés | Poste | Fin |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/01/2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Directeur Général | 01/01/2000 |
Formation de Cyrus Harmon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
